Article
A potential mechanism underlying the increased susceptibility of individuals with a polymorphism in NAD(P)H:quinone oxidoreductase 1 (NQO1) to benzene toxicity.
Proceedings of the National Academy of Sciences of the United States of America - 6 Jul 1999
Moran J L, Siegel D, Ross D
Abstract excerpt
NAD(P)H:quinone oxidoreductase 1 (NQO1) is a two-electron reductase that detoxifies quinones derived from the oxidation of phenolic metabolites of benzene. A polymorphism in NQO1, a C609T substitution, has been identified, and individuals homozygous for this change (T/T) have no detectable NQO1. Exposed workers with a T/T genotype have an increased risk of benzene hematotoxicity. This finding suggests NQO1 is...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
